About NRG GY018: Pembrolizumab Plus Chemotherapy in Endometrial Cancer
John Nakayama, MD, discusses the significance of the NRG GY018 study in endometrial cancer.
Discussing Recent Advances for Patients With Endometrial Cancer
John Nakayama, MD, discusses what the evolution of endometrial cancer treatment has looked like in recent years.